• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • Historical romance: In 1906, an Englishwoman is infatuated by the handsome Indian groom of her horse
    • Review: Rekha is the life and soul of Muzaffar’s Ali’s classic ‘Umrao Jaan’
    • ‘Map of Memories’: Experimental poems resonate with the poet’s identity as migrant, scholar, thinker
    • Why Adani’s Dharavi redevelopment plan has run into resistance from some residents
    • What Iranians in India think about the war and Tehran
    • Why EC move to create new Bihar voter list has rung the ‘NRC’ alarm bell
    • ‘What we saw...we captured in the camera’: Rural Rajasthan, through the eyes of its own residents
    • In Bengaluru, an ancient play finds new voice in the world’s oldest living dramatic tradition
    • Row erupts after Trinamool Congress MLA’s remarks about Kolkata law student gangrape case
    • Through a reader’s eyes: Bloomsday celebrations in James Joyce’s city, Dublin
    • Bike taxis are exploding in India – but are facing government roadblocks
    • Harsh Mander: The plunder and loot by private healthcare in India
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

compulsory licencing

  • Bad news for patients as the government weakens the drug price regulator and meddles with price caps

    Bad news for patients as the government weakens the drug price regulator and meddles with price caps

    S Srinivasan
    · Mar 08, 2019 · 02:30 pm
  • Switzerland wants stricter intellectual property rules in India that could harm generic drug makers

    Switzerland wants stricter intellectual property rules in India that could harm generic drug makers

    Jyotsna Singh
    · Mar 23, 2017 · 07:03 pm